HomeCare Pro

This cutting-edge device is designed to revolutionize the way patients access medical care by offering a powerful and easy-to-use remote patient monitoring solution.

With the HomeCare Pro, patients can conduct 80% of the usual doctor visits from the comfort of their own homes, significantly improving access to healthcare and reducing the need for in-person appointments. By seamlessly combining temperature measurement, heart and lung auscultation, and advanced visual examination capabilities, the HomeCare Pro allows patients to receive professional assessments without leaving their homes.

The solution is the combination of a new medical device and software to enable a doctor to consult a patient online but also have much more ability to diagnose more precisely. 

The device can measure a person's temperature, listen to the heart and lungs, and it has a camera to check the throat, ears, and nose. Connected mobile phone can streamline the sound/video to a doctor through our telehealth platform. 

Currently, the solution is created to target Ukrainian citizens who are close to the frontline and don't have the possibility to go to the hospital to visit a doctor due to obvious reasons. 

But the solution can be used anywhere in the world and the target population can be:

1. Individuals in remote or rural areas: Those who live far from healthcare facilities or in areas with limited access to healthcare professionals can greatly benefit from the HomeCare Pro, as it enables them to receive medical assessments and consultations without the need for extensive travel.

2. Elderly and disabled individuals: People with limited mobility, such as the elderly or those with disabilities, can use the HomeCare Pro to access healthcare services more comfortably from their homes, reducing the physical strain and logistical challenges of attending in-person appointments.

3. Patients with chronic conditions: Individuals managing chronic illnesses that require regular monitoring can use the HomeCare Pro to track their health and share data with their healthcare providers for more efficient care management.

4. Parents with young children: The HomeCare Pro can be particularly helpful for parents who need to monitor their children's health frequently, enabling them to receive professional guidance without the need for numerous visits to a healthcare facility.

BeKey is a tech company with more than 10 years of experience developing digital health solutions around the world. We understand all the regulations and requirements for each technical solution for this industry, know how to protect PHI and engage patients. 

Now we are aiming to help every Ukrainian who is affected by war but we are sure our solution can help thousands of people around the world. Solve can help us access these communities. 

We are currently at the stage of starting a pilot and getting evidence of the solution's accuracy. We are trying to send the device to the frontline of Ukrainian forces to help civilians who are still there and can't have access to normal healthcare. The pilot should start in early June. 

We need financial support and mentorship since we are a tech company with limited access to communities that lack healthcare access. We are sure our device can help many people worldwide but we need help reaching these communities.

Funds would be used to improve the device after we collect more feedback from doctors and manufacture more copies. 

But help to access more communities is more important for us. We are happy to start more pilots in other countries besides Ukraine. 

There are lots of similar medical devices trying to solve the same problem.

But there is usually a separate device for each measurement and very few solutions that can do all diagnostics the HomeCare Pro can. Also, our device should be much cheaper than any of the competitors on the market so much more changes it can be affordable for developing countries. 

For this year our main goal is to finalize the device, collect lots of feedback and start helping real patients who need it. 

For the future, we'll have to plan mass manufacturing and add more biomarkers to measure to it. Distribution is of course another problem we need to solve. 

We have exact goals that help us measure the progress of the solution development:

1. 3-5 pilots in different regions.

2. Collect evidence the solution properly works and helps to improve the accuracy of diagnosis. 

3. Finalize the device and start manufacturing the final version. 

(All three items should be completed by mid-fall of 2023) 

4. Start mass manufacturing and find distribution channels by the end of 2023. 

Home care is obviously a new trend that started during the pandemic. Remote patient monitoring is a part of it. While lots of startups develop incredible and innovative solutions to measure different biomarkers, healthcare equity and access to healthcare is still huge problem around the world. 

We truly believe that our solution should help solve this problem and we'll see the impact already in a pilot stage. 

Until we apply for the patent, the list of technologies and hardware components is under NDA.

We already had a first trial of the prototype in one of the hospitals in Ukraine. After collecting all the feedback, we are working on a new version of device which will be much more improved and flexible.

Sincerity and Respect are the key values of our organization (https://bekey.io/mission). We hire employees only by the means of their skills and experience. We have employees of multiple races, the gender percentage of the company is almost even.

The business models we consider may vary depending on the region and healthcare systems. For countries with mandatory medical insurance - insurance companies are the ones that would cover the expenses of solution use. 

In other cases, the HomeCare Pro device should be purchased by the patients but our goal is to make the price as low as possible so everyone can afford it. 

After we are done with pilots and finalize the device, we plan to start selling the solution and become profitable by fall of 2024. 

At the moment we financed this project completely by ourselves as a company but for this specific product, we can't provide a successful example yet.